CN Patent

CN111918647A — 用于治疗眼痛的nk-1拮抗剂

Assigned to Ospedale San Raffaele SRL · Expires 2020-11-10 · 6y expired

What this patent protects

本发明涉及用于治疗眼敏感和/或眼痛的化合物，特别是NK‑1拮抗剂。

USPTO Abstract

本发明涉及用于治疗眼敏感和/或眼痛的化合物，特别是NK‑1拮抗剂。

Drugs covered by this patent

rolapitant-hydrochloride (ROLAPITANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN111918647A
Jurisdiction: CN
Classification: —
Expires: 2020-11-10
Drug substance claim: No
Drug product claim: No
Assignee: Ospedale San Raffaele SRL
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.